vs
GYRE THERAPEUTICS, INC.（GYRE）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
RCI HOSPITALITY HOLDINGS, INC.的季度营收约是GYRE THERAPEUTICS, INC.的1.9倍（$70.9M vs $37.2M），GYRE THERAPEUTICS, INC.净利率更高（-3.7% vs -7.8%，领先4.1%），GYRE THERAPEUTICS, INC.同比增速更快（33.4% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $-5.8M），过去两年GYRE THERAPEUTICS, INC.的营收复合增速更高（17.0% vs -2.0%）
GYRE Therapeutics是一家临床阶段生物制药企业，专注于开发针对难治性血液系统恶性肿瘤和实体瘤的新型靶向疗法，聚焦精准肿瘤学领域以满足未被满足的患者医疗需求，主要在北美地区开展业务。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
GYRE vs RICK — 直观对比
营收规模更大
RICK
是对方的1.9倍
$37.2M
营收增速更快
GYRE
高出36.6%
-3.1%
净利率更高
GYRE
高出4.1%
-7.8%
自由现金流更多
RICK
多$17.3M
$-5.8M
两年增速更快
GYRE
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.2M | $70.9M |
| 净利润 | $-1.4M | $-5.5M |
| 毛利率 | 95.3% | — |
| 营业利润率 | 0.3% | -0.7% |
| 净利率 | -3.7% | -7.8% |
| 营收同比 | 33.4% | -3.1% |
| 净利润同比 | -340.1% | -2354.9% |
| 每股收益（稀释后） | $-0.01 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GYRERICK
| Q4 25 | $37.2M | — | ||
| Q3 25 | $30.6M | $70.9M | ||
| Q2 25 | $26.8M | $71.1M | ||
| Q1 25 | $22.1M | $65.9M | ||
| Q4 24 | $27.9M | $71.5M | ||
| Q3 24 | $25.5M | $73.2M | ||
| Q2 24 | $25.2M | $76.2M | ||
| Q1 24 | $27.2M | $72.3M |
净利润GYRERICK
| Q4 25 | $-1.4M | — | ||
| Q3 25 | $5.9M | $-5.5M | ||
| Q2 25 | $1.6M | $4.1M | ||
| Q1 25 | $3.7M | $3.2M | ||
| Q4 24 | $569.0K | $9.0M | ||
| Q3 24 | $2.9M | $244.0K | ||
| Q2 24 | $4.5M | $-5.2M | ||
| Q1 24 | $9.9M | $774.0K |
毛利率GYRERICK
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
营业利润率GYRERICK
| Q4 25 | 0.3% | — | ||
| Q3 25 | 22.7% | -0.7% | ||
| Q2 25 | 8.1% | 12.2% | ||
| Q1 25 | 10.3% | 12.4% | ||
| Q4 24 | 2.4% | 19.5% | ||
| Q3 24 | 16.6% | 4.8% | ||
| Q2 24 | 12.7% | -3.3% | ||
| Q1 24 | 29.7% | 6.4% |
净利率GYRERICK
| Q4 25 | -3.7% | — | ||
| Q3 25 | 19.4% | -7.8% | ||
| Q2 25 | 5.9% | 5.7% | ||
| Q1 25 | 16.9% | 4.9% | ||
| Q4 24 | 2.0% | 12.6% | ||
| Q3 24 | 11.2% | 0.3% | ||
| Q2 24 | 18.0% | -6.9% | ||
| Q1 24 | 36.6% | 1.1% |
每股收益（稀释后）GYRERICK
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $0.03 | $-0.60 | ||
| Q2 25 | $0.00 | $0.46 | ||
| Q1 25 | $0.00 | $0.36 | ||
| Q4 24 | $0.00 | $1.01 | ||
| Q3 24 | $0.01 | $0.04 | ||
| Q2 24 | $0.01 | $-0.56 | ||
| Q1 24 | $0.03 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.4M | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $106.0M | $261.1M |
| 总资产 | $166.1M | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资GYRERICK
| Q4 25 | $52.4M | — | ||
| Q3 25 | $60.0M | $33.7M | ||
| Q2 25 | $54.4M | $29.3M | ||
| Q1 25 | $29.9M | $32.7M | ||
| Q4 24 | $26.7M | $34.7M | ||
| Q3 24 | $25.1M | $32.4M | ||
| Q2 24 | $25.1M | $34.9M | ||
| Q1 24 | $37.4M | $20.0M |
总债务GYRERICK
| Q4 25 | — | — | ||
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GYRERICK
| Q4 25 | $106.0M | — | ||
| Q3 25 | $101.9M | $261.1M | ||
| Q2 25 | $92.0M | $269.5M | ||
| Q1 25 | $68.1M | $268.8M | ||
| Q4 24 | $63.3M | $269.0M | ||
| Q3 24 | $63.2M | $263.4M | ||
| Q2 24 | $60.4M | $271.2M | ||
| Q1 24 | $56.6M | $285.8M |
总资产GYRERICK
| Q4 25 | $166.1M | — | ||
| Q3 25 | $159.4M | $596.9M | ||
| Q2 25 | $152.6M | $597.4M | ||
| Q1 25 | $129.8M | $589.8M | ||
| Q4 24 | $125.4M | $586.2M | ||
| Q3 24 | $125.2M | $584.4M | ||
| Q2 24 | $120.9M | $601.0M | ||
| Q1 24 | $122.0M | $609.9M |
负债/权益比GYRERICK
| Q4 25 | — | — | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.6M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $-5.8M | $11.5M |
| 自由现金流率自由现金流/营收 | -15.5% | 16.2% |
| 资本支出强度资本支出/营收 | 0.4% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-180.0K | $34.9M |
8季度趋势，按日历期对齐
经营现金流GYRERICK
| Q4 25 | $-5.6M | — | ||
| Q3 25 | $4.7M | $13.7M | ||
| Q2 25 | $2.1M | $13.8M | ||
| Q1 25 | $-129.0K | $8.5M | ||
| Q4 24 | $-2.8M | $13.3M | ||
| Q3 24 | $1.7M | $15.7M | ||
| Q2 24 | $-5.5M | $15.8M | ||
| Q1 24 | $2.9M | $10.8M |
自由现金流GYRERICK
| Q4 25 | $-5.8M | — | ||
| Q3 25 | $4.0M | $11.5M | ||
| Q2 25 | $1.8M | $10.1M | ||
| Q1 25 | $-251.0K | $5.7M | ||
| Q4 24 | $-2.8M | $7.6M | ||
| Q3 24 | $1.0M | $10.3M | ||
| Q2 24 | $-6.9M | $9.3M | ||
| Q1 24 | $2.7M | $3.2M |
自由现金流率GYRERICK
| Q4 25 | -15.5% | — | ||
| Q3 25 | 13.1% | 16.2% | ||
| Q2 25 | 6.8% | 14.2% | ||
| Q1 25 | -1.1% | 8.6% | ||
| Q4 24 | -10.1% | 10.6% | ||
| Q3 24 | 4.1% | 14.0% | ||
| Q2 24 | -27.5% | 12.3% | ||
| Q1 24 | 9.8% | 4.4% |
资本支出强度GYRERICK
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.2% | 3.2% | ||
| Q2 25 | 1.0% | 5.2% | ||
| Q1 25 | 0.6% | 4.3% | ||
| Q4 24 | 0.2% | 8.0% | ||
| Q3 24 | 2.7% | 7.3% | ||
| Q2 24 | 5.8% | 8.4% | ||
| Q1 24 | 0.9% | 10.6% |
现金转化率GYRERICK
| Q4 25 | — | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 1.32× | 3.40× | ||
| Q1 25 | -0.03× | 2.65× | ||
| Q4 24 | -4.85× | 1.48× | ||
| Q3 24 | 0.60× | 64.14× | ||
| Q2 24 | -1.21× | — | ||
| Q1 24 | 0.29× | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GYRE
暂无分部数据
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
